Hei fair-lady. Now it has a much more advanced manufacturing plant, ADCOM resounding approval, more hiring, more patents, and much closer to marketing. That was financed with shares, hence the relative pps drop, but the market valuation is higher. The fat that pigs like you play (legally or illegally) with the price on a minute to minute basis is painful to the company and shareholders in the short term, but in the long term you will be fukkked and that's exactly what should happen to the likes of you, and worse. You are the exemplification of what's worse with humanity.
Speculation drives stock prices until sales begin, and investors can actually calculate the value of the company. If a given outcome of an event is certain, then there is no more speculation, and the value of that outcome will be already baked into the current price of the stock.
This is the case with MNKD. Approval is certain, and hence dont expect any major upward movement if FDA's official approval announcement is made. If the approval is delayed, or rejected, this will nose dive
It will still be speculation even after FDA as sales are not in and people will speculate higher or lower, till news on marketing front starts coming in, sales, patient chatter, doctor chatter, etc. Speculation will be good at that time as the shorts will be caught with the shorts to their knees bending over to pick a penny from the shower floor for their lunch.